TY - JOUR AU - Stillion, Jenefer R AU - Boysen, Søren R PY - 2017/12/12 Y2 - 2024/03/28 TI - Does Adding Transdermal Nitroglycerine to Other Therapies Used for Management of Left-sided Congestive Heart Failure in Dogs Speed the Resolution of Clinical Signs? JF - Veterinary Evidence JA - VE VL - 2 IS - 4 SE - Knowledge Summaries DO - 10.18849/ve.v2i4.115 UR - https://veterinaryevidence.org/index.php/ve/article/view/115 SP - AB - <p><strong><strong>There is an erratum to this paper published in&nbsp;<em>Veterinary Evidence</em>&nbsp;Vol 3, Issue 1 (2018):&nbsp;<a id="pub-id::doi" href="/index.php/ve/article/view/168/220" target="_blank" rel="noopener">http://dx.doi.org/10.18849/ve.v3i1.168</a></strong></strong></p><p><strong>Clinical bottom line</strong></p><p>There is very weak veterinary clinical and experimental evidence based upon a limited number of studies to indicate that adding transdermal nitroglycerine to other therapies used for management of left-sided congestive heart failure in dogs speeds the resolution of clinical signs.</p><p>&nbsp;</p><p><br><img src="https://www.veterinaryevidence.org/rcvskmod/icons/oa-icon.jpg" alt="Open Access"> <img src="https://www.veterinaryevidence.org/rcvskmod/icons/pr-icon.jpg" alt="Peer Reviewed"></p> ER -